Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China
- PMID: 30868740
- PMCID: PMC6488134
- DOI: 10.1002/cam4.2052
Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China
Abstract
Prediction of early postoperative recurrence is of great significance for follow-up treatment. However, there are few studies available that focus on high-risk factors of early postoperative recurrence or even the definition the exact time of early recurrence for hilar cholangiocarcinoma. Thus, we aimed to examine the optimal cut-off value for defining the early in patients with R0 resection of hilar cholangiocarcinoma and to investigate prognostic factors associated with early recurrence. Two hundred and fifty-eight patients with R0 resection of hilar cholangiocarcinoma between 2000 and 2015 were included. The minimum P value approach was used to define the optimal cut-off of early recurrence. The prognostic factors associated with early recurrence were investigated. The optimal cut-off value for dividing patients into early and non-early recurrence groups after R0 resection of hilar cholangiocarcinoma was 12 months. Sixty-two patients were recorded as early recurrence, and the remaining 196 patients were labeled as non-early recurrence. Multivariate logistic regression analysis indicated lymph node metastasis (OR = 2.756, 95% CI 1.409-5.393; P = 0.003), poor differentiation (OR = 1.653; 95% CI 1.040-2.632; P = 0.034), increased postoperative CA 19-9 levels (OR = 1.965, 95% CI 1.282-3.013; P = 0.002), neutrophil-to-lymphocyte ratio > 3.41 (OR = 5.125, 95% CI 2.419-10.857; P < 0.001) and age > 60 years (OR = 2.018, 95% CI 1.032-3.947; P = 0.040) were independent determinants of early and non-early recurrence. Poor differentiation (HR = 2.609, 95% CI 1.600-4.252; P < 0.001), Bismuth classification type III/IV (HR = 2.510, 95% CI 1.298-4.852; P = 0.006) and perineural invasion (HR=2.380, 95% CI 1.271-4.457; P = 0.007) were independent factors of overall survival in the subgroup of patients who developed early recurrence. The optimal cut-off value for dividing early recurrence after R0 resection of hilar cholangiocarcinoma was 12 months. Tumor differentiation, Bismuth classification, and perineural invasion were independent factors of overall survival in the subgroup of patients with early recurrence. Patients with risk factors should be monitored closely after curative surgery.
Keywords: early recurrence; hilar cholangiocrcinoma; prognosis; survival.
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
We declare that we have no conflict of interest.
Figures
Similar articles
-
Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.World J Gastroenterol. 2016 Feb 28;22(8):2601-10. doi: 10.3748/wjg.v22.i8.2601. World J Gastroenterol. 2016. PMID: 26937148 Free PMC article.
-
Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?Oncotarget. 2017 Jul 11;8(28):45335-45344. doi: 10.18632/oncotarget.17336. Oncotarget. 2017. PMID: 28484084 Free PMC article.
-
Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.J Gastrointest Surg. 2020 Feb;24(2):330-340. doi: 10.1007/s11605-018-04086-9. Epub 2019 Jan 22. J Gastrointest Surg. 2020. PMID: 30671792 Free PMC article.
-
[Klatskin tumor. A study of 15 resected cases].Chirurgie. 1999 Apr;124(2):132-9; discussion 139-40. doi: 10.1016/s0001-4001(99)80055-5. Chirurgie. 1999. PMID: 10349749 Review. French.
-
Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis.Eur J Surg Oncol. 2014 May;40(5):489-495. doi: 10.1016/j.ejso.2014.02.231. Epub 2014 Feb 28. Eur J Surg Oncol. 2014. PMID: 24685155 Review.
Cited by
-
Survival analysis of laparoscopic surgery and open surgery for hilar cholangiocarcinoma: a retrospective cohort study.World J Surg Oncol. 2024 Feb 19;22(1):58. doi: 10.1186/s12957-024-03327-3. World J Surg Oncol. 2024. PMID: 38369496 Free PMC article.
-
Application of AI on cholangiocarcinoma.Front Oncol. 2024 Jan 29;14:1324222. doi: 10.3389/fonc.2024.1324222. eCollection 2024. Front Oncol. 2024. PMID: 38347839 Free PMC article. Review.
-
New Imaging Techniques.Recent Results Cancer Res. 2023;219:109-145. doi: 10.1007/978-3-031-35166-2_6. Recent Results Cancer Res. 2023. PMID: 37660333
-
Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection.Ann Hepatobiliary Pancreat Surg. 2023 May 31;27(2):158-165. doi: 10.14701/ahbps.22-114. Epub 2023 Feb 20. Ann Hepatobiliary Pancreat Surg. 2023. PMID: 36804209 Free PMC article.
-
Preoperative risk factors for early recurrence after resection of perihilar cholangiocarcinoma.BJS Open. 2022 Sep 2;6(5):zrac115. doi: 10.1093/bjsopen/zrac115. BJS Open. 2022. PMID: 36125346 Free PMC article.
References
-
- Hakeem AR, Marangoni G, Chapman SJ, et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil‐lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastro Hepatol. 2014;26:1047‐1054. - PubMed
-
- Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202:310‐320. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
